Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
These modifications significantly reduce binding affinity for IGF binding proteins (IGFBPs 1 through 6), extending functional availability in in vitro assay systems
Researchers studying the distinction between physiological and pharmacological GH signalling will find this a meaningful design consideration in protocol selection
No thyroid C-cell tumors were observed in human trial participants, though this risk carries a theoretical basis from rodent studies and is listed as a precaution, as it is with all GLP-1 class compounds
No noticeable effect: in research terms, FOXO4-DRI only acts where senescent cells are present, and degraded or mislabeled product loses activity
For mild deficiencies, you may need two to three injections over several weeks to notice peak impact
These effects are generally mild and resolve within the first week
US$ 22.73
US$ 28.86
US$ 27.46
US$ 25.89
